Gara Jalqabaatti › Leukemia Myeloidii Hamaa
Qorannoo klinikaalii Leukemia Myeloidii Hamaa Ameerikaa Keessatti hirmaatuu
Qorannoo 276 Leukemia Myeloidii Hamaa f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 85
- New York City, NYQorannoo 51
- Boston, MAQorannoo 44
- Baldwin Park, CAQorannoo 40
- Seattle, WAQorannoo 40
- Columbus, OHQorannoo 35
- Philadelphia, PAQorannoo 34
- Durham, NCQorannoo 33
- Atlanta, GAQorannoo 30
- Tampa, FLQorannoo 29
- Chicago, ILQorannoo 26
- Portland, ORQorannoo 25
- Miami, FLQorannoo 24
- Washington, DCQorannoo 24
- Los Angeles, CAQorannoo 24
- St. Louis, MOQorannoo 22
- Dallas, TXQorannoo 21
- Nashville, TNQorannoo 21
- Birmingham, ALQorannoo 21
- Queens, NYQorannoo 21
- Cincinnati, OHQorannoo 20
- Cleveland, OHQorannoo 20
- Edison, NJQorannoo 20
- Minneapolis, MNQorannoo 20
- Buffalo, NYQorannoo 19
- Mountain View, CAQorannoo 19
- Baltimore, MDQorannoo 19
- Pittsburgh, PAQorannoo 18
- Winston-Salem, NCQorannoo 18
- Greenburgh, NYQorannoo 18
- Salt Lake City, UTQorannoo 17
- Ann Arbor, MIQorannoo 17
- New Haven, CTQorannoo 17
- Milwaukee, WIQorannoo 17
- Rochester, NYQorannoo 16
- Charlotte, NCQorannoo 16
- Aurora, COQorannoo 16
- Charlottesville, VAQorannoo 16
- Cedar Rapids, IAQorannoo 16
- Madison, WIQorannoo 16
Naannoon
- AlabamaQorannoo 21
- ArizonaQorannoo 22
- ArkansasQorannoo 13
- CaliforniaQorannoo 79
- ColoradoQorannoo 22
- ConnecticutQorannoo 17
- DelawareQorannoo 7
- Distaarikii KoloombiyaaQorannoo 10
- FloridaQorannoo 55
- GeorgiaQorannoo 38
- HawaiiQorannoo 7
- IdahoQorannoo 9
- IllinoisQorannoo 31
- IndianaQorannoo 14
- IowaQorannoo 17
- KansasQorannoo 20
- KentuckyQorannoo 14
- LouisianaQorannoo 13
- MaineQorannoo 9
- MarylandQorannoo 31
- MassachusettsQorannoo 45
- MichiganQorannoo 24
- MinnesotaQorannoo 27
- MississippiQorannoo 8
- MissouriQorannoo 23
- MontanaQorannoo 6
- NebraskaQorannoo 10
- NevadaQorannoo 9
- New HampshireQorannoo 9
- New JerseyQorannoo 32
- New MexicoQorannoo 9
- New YorkQorannoo 71
- North CarolinaQorannoo 43
- North DakotaQorannoo 4
- OhioQorannoo 57
- OklahomaQorannoo 14
- OregonQorannoo 27
- PennsylvaniaQorannoo 45
- Rhode IslandQorannoo 11
- South CarolinaQorannoo 16
- South DakotaQorannoo 6
- TennesseeQorannoo 31
- TexasQorannoo 94
- UtahQorannoo 17
- VermontQorannoo 7
- VirginiaQorannoo 24
- WashingtonQorannoo 41
- West VirginiaQorannoo 6
- WisconsinQorannoo 25
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07581002Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07437950Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07304011Assessment of Geriatric Evaluations Impact on New AML Guidance
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05909501Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06904066Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07723703Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06484062Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 0 hanga 38 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06131801A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 hanga 78 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT03802695A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT06763341Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05554393A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06852222MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05564390Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT03629171A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06548230Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07211958Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT03874052Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06398457Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT03661307Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06871410A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05360160A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
Hanga umuriin 21 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07012044Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06317649A Study of CRD3874-SI in People With Leukemia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07661095Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.